The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2020

Filed:

Nov. 05, 2015
Applicant:

Optibiotix Limited, Heslington, GB;

Inventor:
Assignee:

OPTIBIOTIX LIMITED, Heslington, York, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/135 (2016.01); A61K 31/702 (2006.01); A61K 31/733 (2006.01); A61K 31/736 (2006.01); A61K 35/741 (2015.01); A23L 29/244 (2016.01); A23L 33/00 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A61K 45/06 (2006.01); A23L 33/21 (2016.01); A61K 33/24 (2019.01); A61K 9/48 (2006.01); A23C 9/123 (2006.01); A23C 9/13 (2006.01); A23C 9/133 (2006.01); A23C 9/137 (2006.01); A23C 17/02 (2006.01); A23C 19/06 (2006.01); A61K 35/744 (2015.01); A61K 35/747 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A23L 33/135 (2016.08); A23C 9/1238 (2013.01); A23C 9/133 (2013.01); A23C 9/137 (2013.01); A23C 9/1307 (2013.01); A23C 9/1322 (2013.01); A23C 17/02 (2013.01); A23C 19/062 (2013.01); A23L 29/244 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/21 (2016.08); A23L 33/30 (2016.08); A23L 33/40 (2016.08); A61K 9/48 (2013.01); A61K 31/702 (2013.01); A61K 31/733 (2013.01); A61K 31/736 (2013.01); A61K 33/24 (2013.01); A61K 35/741 (2013.01); A61K 35/744 (2013.01); A61K 35/747 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/15 (2013.01); A23Y 2220/29 (2013.01); A23Y 2240/75 (2013.01); A61K 2035/115 (2013.01);
Abstract

The present invention relates to compositions for use and formulation as weight management products and in particular fermented dairy foodstuffs. The compositions generally comprise two or more of the following components: a) a microbiome modifying component; b) a satiety modifying component; and c) a metabolic modifying 5 component and at least one of the following: d)CBS 139100 andsubsp.CBS 139099 microbial strains or mutant strains or fragments or fractions thereof; e) a combination ofandsubsp.microbial strains which together, or individually, are capable of secreting polysaccharides having high levels of galactosamine 10 and no or low levels of rhamnose and glucuronic acid when grown on a dairy substrate; or f) polysaccharides formed of: i) 15-25% galactosamine; ii) 45-60% galactose; and iii) 20-30% glucose. The compositions may also be useful in the management or treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease.


Find Patent Forward Citations

Loading…